Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

122

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

December 11, 2021

Study Completion Date

December 11, 2021

Conditions
Analgesia
Interventions
DRUG

Dexmedetomidine

IV injection (1 µg/kg - 100 mL) before anesthetic induction

DRUG

Ropivacaine

Perinervous injection between C5 and C6 nerve roots / interscalene block (0.75% - 20 mL)

DRUG

Dexamethasone

IV injection (0.15 mg/kg) during anesthetic induction

Trial Locations (1)

Unknown

Hôpital privé jean Mermoz, Lyon

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Euraxi Pharma

INDUSTRY

lead

GCS Ramsay Santé pour l'Enseignement et la Recherche

OTHER

NCT04394481 - Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery | Biotech Hunter | Biotech Hunter